本文介绍了抗血小板聚集药物的研究概况，并对抗血小板药物帕米格雷的药代动力学和药效学特征作了简要综述。
The development of anti-platelet agents was described in this paper. Pamicogrel, a new anti-platelet drug, was introduced in detail, including its pharmacokinetics and pharmacodynamics.
方法：调查某院2003~2006年初次发生脑梗死住院患者的病历，统计、分析其用药情况。结果：该院应用频率较高的有脱水药、 利尿药、抗血小板聚集药、改善脑血循环药及支持治疗药；
METHODS: Medical records of patients in who acute cerebral infarction occurred for the first time in a hospital during 2003~2006 were analyzed statistically in respect of drug use.
以磷脂酶c (PLC)肠溶性微囊粉经犬胃给药，检测其抗血小板聚集作用和检测犬血浆中plc的含量。
The micro capsule powder of enteric-characteristic PLC was given after the stomach. The anti-aggregation of blood platelet and content of PLC were detected in dog blood plasma.
应用推荐